GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] small molecule — what am I missing here — 67 comments in the full submission. View in context.
1k
c/orforglipron·submitted 2 years ago by u/bruno_dumitru

[Question] small molecule — what am I missing here

Questionbranch of 6 comments

small molecule — what am I missing here. Searched first, found three threads that contradict each other, hence the post. Compared milligram figures across two completely different molecule classes in a comment. Deserved the correction. Went looking for independent testing on this and found essentially nothing, which…

Read the full submission and all 67 comments →

This branch

6 comments, started 2 years ago
u/pancreatitis_scare129 points·2 years ago

The analytical point, which this board keeps getting wrong by importing habits from the peptide side.

For a peptide, purity is typically reported as area percent by HPLC with identity by mass spectrometry, and the impurity classes are things like deletion and oxidation products. For a small molecule the relevant impurities are synthetic intermediates, degradants and residual solvents, and identity is established differently.

So the certificate you would want looks different, the questions to ask are different, and a "purity" figure quoted here is not comparable to one quoted on the peptide boards. Anybody posting a result should say what method produced it, which is good practice everywhere and essential here.

replysharereportpermalink
u/greta_nilsen44 points·2 years ago

Read both programme names carefully after mixing them up in a comment and being politely corrected.

replysharereportpermalink
[deleted]49 points·2 years ago

[deleted]

replysharereportpermalink
u/erez_yilmaz40 points·2 years ago

oral semaglutide is a peptide with an absorption enhancer, this is not that

replysharereportpermalink
u/dilara_weiss20 points·2 years ago

do not assume reconstitution intuitions apply, there is nothing to reconstitute

replysharereportpermalink
u/maren_sorensen22 points·2 years ago

Disagree. You are comparing doses across a small molecule and a peptide, which is not a comparison of anything.

replysharereportpermalink

← back to the whole thread

About c/orforglipron

The small-molecule oral: why a non-peptide agonist escapes the absorption problems of oral semaglutide, what the ATTAIN and ACHIEVE readouts showed, and what a pill with no refrigeration requirement would do to the entire supply conversation this site is built around.

21kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/orforglipron rules
  1. Small molecule, not a peptide. Purity discussion here is a different problem.
  2. Cite ATTAIN/ACHIEVE arms specifically when quoting numbers.
  3. Availability speculation must be flaired Speculation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.